Cited by 168Cardiomyopathy and Myosin StudiesCardiac electrophysiology and arrhythmiasCardiovascular Effects of Exercise

The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.

Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies

Open access

Yotti, Raquel, Seidman, Christine E., Seidman, Jonathan G.·2019·Annual Review of Genomics and Human Genetics

DOI 10.1146/annurev-genom-083118-015306

Open this paper in CoChat — free account Open PDF

Abstract

Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are common heart muscle disorders that are caused by pathogenic variants in sarcomere protein genes. HCM is characterized by unexplained cardiac hypertrophy (increased chamber wall thickness) that is accompanied by enhanced cardiac contractility and impaired relaxation. DCM is defined as increased ventricular chamber volume with contractile impairment. In this review, we discuss recent analyses that provide new insights into the molecular mechanisms that cause these conditions. HCM studies have uncovered the critical importance of conformational changes that occur during relaxation and enable energy conservation, which are frequently disturbed by HCM mutations. DCM studies have demonstrated the considerable prevalence of truncating variants in titin and have discerned that these variants reduce contractile function by impairing sarcomerogenesis. These new pathophysiologic mechanisms open exciting opportunities to identify new pharmacological targets and develop future cardioprotective strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-genom-083118-015306

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Contemporary Definitions and Classification of the Cardiomyopathies
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424
Self-citation
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Self-citation
A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
Self-citation
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
Pinto, Y. M., Elliot, P. M., Arbustini, E., Adler, Y., Anastasakis, A., Böhm, M., Duboc, D., Gimeno, J. R., de Groote, P., Imazio, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv727 · Cited by 1,122
Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children
Towbin, J. A., Lowe, A. M., Colan, S. D., Sleeper, L. A., Orav, E. J., Clunie, S. K., Messere, J. E., Cox, G. F., Lurie, P. R., Hsu, D. T., et al. (2006) · JAMA · doi:10.1001/jama.296.15.1867 · Cited by 1,055
Dilated cardiomyopathy: the complexity of a diverse genetic architecture
Hershberger, R. E., Hedges, D. J., & Morales, A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.105 · Cited by 1,036

Show all 154 references

Research works printed but not linked: 2

Gersh BJ, 2011, Circulation, 124, e783
Walsh R, 2017, Eur. Heart J., 38, 3461

Sorted by citations

Cardiomyocyte Maturation: New Phase in Development
Guo, Y., & Pu, W. T. (2020) · Circulation Research · doi:10.1161/circresaha.119.315862 · Cited by 653
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity
Harper, A. R., Goel, A., Grace, C., Thomson, K. L., Petersen, S. E., Xu, X., Waring, A., Ormondroyd, E., Kramer, C. M., Ho, C. Y., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00764-0 · Cited by 353
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
Reichart, D., Newby, G. A., Wakimoto, H., Lun, M., Gorham, J. M., Curran, J. J., Raguram, A., DeLaughter, D. M., Conner, D. A., Marsiglia, J. D. C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02190-7 · Cited by 203
Self-citation
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy
Goli, R. R., Li, J., Brandimarto, J., Levine, L. D., Riis, V. M., Mcafee, Q. W., DePalma, S. R., Haghighi, A., Seidman, J. G., Seidman, C. E., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.052395 · Cited by 196
Self-citation
Top-down proteomics: challenges, innovations, and applications in basic and clinical research
Brown, K. A., Melby, J. A., Roberts, D. S., & Ge, Y. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1855982 · Cited by 152
Force Generation by Myosin Motors: A Structural Perspective
Robert‐Paganin, J., Pylypenko, O., Kikuti, C. M., Sweeney, H. L., & Houdusse, A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00264 · Cited by 152
Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due toTTNmutations
Fomin, A., Gärtner, A., Cyganek, L., Tiburcy, M., Tuleta, I., Wellers, L., Folsche, L., Hobbach, A. J., von Frieling-Salewsky, M., Unger, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3079 · Cited by 143
Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy
Previs, M. J., O’Leary, T. S., Morley, M. P., Morley, M. P., Palmer, B., Lewinter, M., Pagani, F. D., Pagani, F. D., Petucci, C., Kim, M., et al. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.009521 · Cited by 108
Structural basis of the super- and hyper-relaxed states of myosin II
Craig, R. W., & Padrón, R. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202113012 · Cited by 84
Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients
Nag, S., Gollapudi, S. K., del Rio, C. L., Spudich, J. A., & McDowell, R. E. (2023) · Science Advances · doi:10.1126/sciadv.abo7622 · Cited by 80
Heart Development and Congenital Structural Heart Defects
Houyel, L., & Meilhac, S. M. (2021) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015012 · Cited by 84
Cardiac sarcomere mechanics in health and disease
Crocini, C., & Gotthardt, M. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00840-7 · Cited by 83
Truncated titin proteins in dilated cardiomyopathy
Mcafee, Q. W., Chen, C. Y., Yang, Y., Caporizzo, M. A., Morley, M. P., Babu, A., Jeong, S., Brandimarto, J., Bedi, K. C., Flam, E. L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd7287 · Cited by 71
Novel Therapies for Prevention and Early Treatment of Cardiomyopathies
Repetti, G. G., Toepfer, C. N., Seidman, J. G., & Seidman, C. E. (2019) · Circulation Research · doi:10.1161/circresaha.119.313569 · Cited by 72
Self-citation
The Sliding Filament Theory Since Andrew Huxley: Multiscale and Multidisciplinary Muscle Research
Powers, J. D., Malingen, S., Regnier, M., & Daniel, T. L. (2021) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-110320-062613 · Cited by 62
The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases
Pourrier, M., & Fedida, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020657 · Cited by 53
Clinical and Diagnostic Value of Highly Sensitive Cardiac Troponins in Arterial Hypertension
Chaulin, A. M. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s315376 · Cited by 46
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy
Ostrominski, J. W., Guo, R., Elliott, P. M., & Ho, C. Y. (2023) · JACC: Heart Failure · doi:10.1016/j.jchf.2023.04.018 · Cited by 42
Making waves: A proposed new role for myosin-binding protein C in regulating oscillatory contractions in vertebrate striated muscle
Harris, S. P. (2020) · The Journal of General Physiology · doi:10.1085/jgp.202012729 · Cited by 43
Reevaluation of the South Asian MYBPC3 Δ25bp Intronic Deletion in Hypertrophic Cardiomyopathy
Harper, A. R., Bowman, M., Hayesmoore, J. B. G., Sage, H. D., Salatino, S., Blair, E. M., Campbell, C., Currie, B., Goel, A., McGuire, K., et al. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002783 · Cited by 42
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy
Suay-Corredera, C., Pricolo, M., Herrero-Galán, E., Velázquez-Carreras, D., Sánchez-Ortiz, D., García-Giustiniani, D., Delgado, J., Galano-Frutos, J., García-Cebollada, H., Vilches, S., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100854 · Cited by 38
Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging
Muresan, I. D., & Agoşton-Coldea, L. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09931-1 · Cited by 39
Protein nanomechanics in biological context
Alegre‐Cebollada, J. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00822-9 · Cited by 38
Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction
Auguin, D., Robert‐Paganin, J., Réty, S., Kikuti, C. M., David, A., Theumer, G., Schmidt, A. W., Knölker, H., & Houdusse, A. (2024) · Nature Communications · doi:10.1038/s41467-024-47587-9 · Cited by 46
Focal Adhesion’s Role in Cardiomyocytes Function: From Cardiomyogenesis to Mechanotransduction
Casarella, S., Ferla, F., Francesco, D. D., Canciani, E., Rizzi, M., & Boccafoschi, F. (2024) · Cells · doi:10.3390/cells13080664 · Cited by 39
DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases
Takeda, Y., Demura, M., Yoneda, T., & Takeda, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094587 · Cited by 37
Dilated cardiomyopathy mutation E525K in human beta-cardiac myosin stabilizes the interacting-heads motif and super-relaxed state of myosin
Rasicci, D. V., Tiwari, P., Bodt, S. M. L., Desetty, R. D., Sadler, F. W., Sivaramakrishnan, S., Craig, R. W., & Yengo, C. M. (2022) · eLife · doi:10.7554/elife.77415 · Cited by 33
Assembly and Maintenance of Sarcomere Thin Filaments and Associated Diseases
Prill, K., & Dawson, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020542 · Cited by 37
A New Therapeutic Framework for Atrial Fibrillation Drug Development
Ang, Y.-S., Rajamani, S., Haldar, S. M., & Hüser, J. (2020) · Circulation Research · doi:10.1161/circresaha.120.316576 · Cited by 38
Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
Wang, Z., Xia, Q., Su, W., Cao, M., Sun, Y., Zhang, M., Chen, W., & Jiang, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.824756 · Cited by 34
RBPMS2 Is a Myocardial-Enriched Splicing Regulator Required for Cardiac Function
Akerberg, A. A., Trembley, M. A., Butty, V. L., Schwertner, A., Zhao, L., Beerens, M., Liu, X., Mahamdeh, M., Yuan, S., Boyer, L. A., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321728 · Cited by 32
Modifications of Titin Contribute to the Progression of Cardiomyopathy and Represent a Therapeutic Target for Treatment of Heart Failure
Tharp, C. A., Mestroni, L., & Taylor, M. R. G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092770 · Cited by 32
Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers
Glavaški, M., Velicki, L., & Vučinić, N. (2023) · Medicina · doi:10.3390/medicina59081424 · Cited by 33
Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation
Sewanan, L. R., Park, J., Rynkiewicz, M. J., Racca, A. W., Papoutsidakis, N., Schwan, J., Jacoby, D. L., Moore, J. R., Lehman, W., Qyang, Y., et al. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202012640 · Cited by 31
The mechanics of the heart: zooming in on hypertrophic cardiomyopathy and cMyBP‐C
Suay‐Corredera, C., & Alegre‐Cebollada, J. (2022) · FEBS Letters · doi:10.1002/1873-3468.14301 · Cited by 31
Advances in mechanical biomarkers
Eroles, M., & Rico, F. (2023) · Journal of Molecular Recognition · doi:10.1002/jmr.3022 · Cited by 31
LncRNAs in cardiac hypertrophy: From basic science to clinical application
Liu, L., Zhang, D., & Li, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15819 · Cited by 29
Novel insights into sarcomere regulatory systems control of cardiac thin filament activation
Solı́s, C., & Solaro, R. J. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202012777 · Cited by 29
A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C
Reinoso, T. R., Landim-Vieira, M., Shi, Y., Johnston, J. R., Chase, P. B., Parvatiyar, M. S., Landstrom, A. P., Pinto, J. R., & Tadros, H. J. J. (2020) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-020-09592-5 · Cited by 27
Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Paci, M., Penttinen, K., Pekkanen-Mattila, M., & Koivumäki, J. T. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000972 · Cited by 25
Exosomally derived Y RNA fragment alleviates hypertrophic cardiomyopathy in transgenic mice
Huang, F., Na, N., Ijichi, T., Wu, X., Miyamoto, K., Ciullo, A., Tran, M., Liang, L., Ibrahim, A. G.-E., Marbán, E., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.014 · Cited by 27
Mono- and Biallelic Protein-Truncating Variants in Alpha-Actinin 2 Cause Cardiomyopathy Through Distinct Mechanisms
Lindholm, M. E., Jimenez‐Morales, D., Zhu, H., Seo, K., Amar, D., Zhao, C., Raja, A. N., Madhvani, R., Abramowitz, S., Espenel, C., et al. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003419 · Cited by 26
Disease association of cyclase-associated protein (CAP): Lessons from gene-targeted mice and human genetic studies
Rust, M. B., & Marcello, E. E. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151207 · Cited by 26
AAV9 gene transfer of cMyBPC N-terminal domains ameliorates cardiomyopathy in cMyBPC-deficient mice
Li, J., Mamidi, R., Doh, C. Y., Holmes, J. B., Bharambe, N. G., Ramachandran, R., & Stelzer, J. E. (2020) · JCI Insight · doi:10.1172/jci.insight.130182 · Cited by 26
Titin: roles in cardiac function and diseases
Stroik, D., Gregorich, Z. R., Raza, F., Ge, Y., & Guo, W. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1385821 · Cited by 28
Contribution of Noncanonical Splice Variants to TTN Truncating Variant Cardiomyopathy
Patel, P. N., Ito, K., Willcox, J. A. L., Haghighi, A., Jang, M. Y., Gorham, J., DePalma, S. R., Lam, L., McDonough, B. A., Johnson, R., et al. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003389 · Cited by 25
Self-citation
Mechanisms of myosin II force generation: insights from novel experimental techniques and approaches
Rassier, D. E., & Månsson, A. (2024) · Physiological Reviews · doi:10.1152/physrev.00014.2023 · Cited by 28
Genetic factors in the pathogenesis of cardio-oncology
Qi, Y., Wei, Y., Li, L., Ge, H., Wang, Y., Zeng, C., & Ma, F. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05537-5 · Cited by 25
Functional Role of Class III Myosins in Hair Cells
Cirilo, J. A., Gunther, L. K., & Yengo, C. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643856 · Cited by 23
Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy
Ušaj, M., Moretto, L., & Månsson, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042195 · Cited by 25
Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model
Baka, T., Moore, J., Qin, F., Yurista, S. R., Zhang, A., He, H., Chambers, J. M., Croteau, D., Goel, R. K., Smith, H. R., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf324 · Cited by 22
Self-citation
The Hidden Fragility in the Heart of the Athletes: A Review of Genetic Biomarkers
Barretta, F., Mirra, B., Monda, E., Caiazza, M., Lombardo, B., Tinto, N., Scudiero, O., Frisso, G., & Mazzaccara, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186682 · Cited by 22
Cardiomyocyte maturation and its reversal during cardiac regeneration
Beisaw, A., & Wu, C. C. (2022) · Developmental Dynamics · doi:10.1002/dvdy.557 · Cited by 21
Modeling Inherited Cardiomyopathies in Adult Zebrafish for Precision Medicine
Ding, Y., Bu, H., & Xu, X. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.599244 · Cited by 21
Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches
Zhou, X., Wang, H., Yan, B., Nie, X., Chen, Q., Yang, X., Lei, M., Guo, X., Ouyang, C., & Ren, Z. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07642-5 · Cited by 22
Chronic Alcohol Intake Exacerbates Cardiac Dysfunction After Myocardial Infarction
Liang, Y., Xu, X., Li, Q., Deng, Y., Xie, M., Zheng, Y., Ou, W., He, Q., Xu, X., Wu, W., et al. (2020) · Alcohol and Alcoholism · doi:10.1093/alcalc/agaa055 · Cited by 19
Cardiomyocyte nuclearity and ploidy: when is double trouble?
Landim-Vieira, M., Schipper, J. M., Pinto, J. R., & Chase, P. B. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09545-7 · Cited by 21
Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy
Wang, Y., Singh, K., Lokman, A. B., Deng, S., Sunitha, B., Lima, J. C., Jr., Beglov, J., Kelly, M., Blease, A., Fung, J. C. K., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3516 · Cited by 18
Self-citation
Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy
Mori, A. A., de Castro, L. R., Bortolin, R. H., Bastos, G. M., de Oliveira, V. F., Ferreira, G. M., Hirata, T. D. C., Fajardo, C. M., Sampaio, M. F., Moreira, D. A. R., et al. (2021) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2021.102478 · Cited by 18
Mechanosignaling pathways alter muscle structure and function by post-translational modification of existing sarcomeric proteins to optimize energy usage
Russell, B., & Solı́s, C. (2021) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-021-09596-9 · Cited by 18
Control of cardiac contractions using Cre-lox and degron strategies in zebrafish
Juan, T., Bellec, M., Cardoso, B., Athéa, H., Fukuda, N., Albu, M., Günther, S., Looso, M., & Stainier, D. Y. R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309842121 · Cited by 16
Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human β-cardiac myosin allosterically
Nandwani, N., Bhowmik, D., Glaser, C., Childers, M. C., Goluguri, R. R., Dawood, A., Regnier, M., Houdusse, A., Spudich, J. A., & Ruppel, K. M. (2025) · Nature Communications · doi:10.1038/s41467-025-63816-1 · Cited by 16
Arrhythmogenic Cardiomyopathy: Exercise Pitfalls, Role of Connexin-43, and Moving beyond Antiarrhythmics
Coscarella, I. L., Landim-Vieira, M., Pinto, J. R., & Chelko, S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158753 · Cited by 16
MYH7 variants cause complex congenital heart disease
Ritter, A. L., Leonard, J., Gray, C., Izumi, K., Levinson, K., Nair, D. R., O’Connor, M. J., Rossano, J., Shankar, V. R., Chowns, J. L., et al. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62766 · Cited by 15
Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TPM1 variant S215L
Halder, S. S., Rynkiewicz, M. J., Creso, J. G., Sewanan, L. R., Howland, L., Moore, J. R., Lehman, W., & Campbell, S. G. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad011 · Cited by 14
Biallelic loss of LDB3 leads to a lethal pediatric dilated cardiomyopathy
Koopmann, T. T., Jamshidi, Y., Naghibi-Sistani, M., van der Klift, H. M., Birjandi, H., Al‐Hassnan, Z. N., Alwadai, A., Zifarelli, G., Karimiani, E. G., Sedighzadeh, S. S., et al. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01204-9 · Cited by 14
Integrating comparative modeling and accelerated simulations reveals conformational and energetic basis of actomyosin force generation
Ma, W., You, S., Regnier, M., & McCammon, J. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215836120 · Cited by 12
Preventing hypocontractility-induced fibroblast expansion alleviates dilated cardiomyopathy
Bretherton, R. C., Reichardt, I. M., Zabrecky, K. A., Nagle, A., Bailey, L. R. J., Bugg, D., Smolgovsky, S. A., Gifford, A. L., McMillen, T. S., Goldstein, A. J., et al. (2025) · Science · doi:10.1126/science.adv9157 · Cited by 13
Implications of S-glutathionylation of sarcomere proteins in cardiac disorders, therapies, and diagnosis
Rosas, P. C., & Solaro, R. J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1060716 · Cited by 13
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
Stern, J. A., Rivas, V. N., Kaplan, J. L., Ueda, Y., Oldach, M. S., Ontiveros, E. S., Kooiker, K. B., van Dijk, S. J., & Harris, S. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-36932-5 · Cited by 13
Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification
Stafford, F., Thomson, K. L., Butters, A., & Ingles, J. (2021) · Current Cardiology Reports · doi:10.1007/s11886-020-01437-4 · Cited by 13
Genetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project
Ormondroyd, E., Grace, C., Borsari, W., Goel, A., McDonough, B. A., Rose, J., Seidman, C. E., & Watkins, H. C. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-024-01660-5 · Cited by 12
Self-citation
Cardiomyocyte Dysfunction in Inherited Cardiomyopathies
Hassoun, R., Budde, H., Mügge, A., & Hamdani, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011154 · Cited by 13
Familial Risk of Dilated and Hypertrophic Cardiomyopathy: A National Family Study in Sweden
Ricci, F., Banihashemi, B., Pirouzifard, M., Sundquist, J., Sundquist, K., Sutton, R., Fedorowski, A., & Zöller, B. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14171 · Cited by 12
A human FLII gene variant alters sarcomeric actin thin filament length and predisposes to cardiomyopathy
Kuwabara, Y., York, A. J., Lin, S. J., Sargent, M. A., Grimes, K. M., Pirruccello, J. P., & Molkentin, J. D. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213696120 · Cited by 11
The molecular mechanism of MiR-26a-5p regulates autophagy and activates NLRP3 inflammasome to mediate cardiomyocyte hypertrophy
Tang, L., Wang, W., Tang, Q.-F., & Wang, L. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03695-w · Cited by 11
MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids
Desai, D. A., Song, T., Singh, R. R., Baby, A., McNamara, J. W., Green, L. C., Nabavizadeh, P., Ericksen, M. B., Bazrafshan, S., Natesan, S., et al. (2024) · Cells · doi:10.3390/cells13221913 · Cited by 10
Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer
Kim, Y., Kim, S. W., Saul, D., Neyazi, M., Schmid, M., Wakimoto, H., Slaven, N., Lee, J., Layton, O., Wasson, L. K., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci183353 · Cited by 13
Self-citation
The Genetic Factors Influencing Cardiomyopathies and Heart Failure across the Allele Frequency Spectrum
Mukhopadhyay, S., Dixit, P., Khanom, N., Sanghera, G., & McGurk, K. A. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10520-y · Cited by 13
Dilated cardiomyopathy mutation in beta-cardiac myosin enhances actin activation of the power stroke and phosphate release
Bodt, S. M. L., Ge, J., Ma, W., Rasicci, D. V., Desetty, R. D., McCammon, J. A., & Yengo, C. M. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae279 · Cited by 10
Ribosomal protein S6 kinase beta-1 gene variants cause hypertrophic cardiomyopathy
Jain, P. K., Jayappa, S., Sairam, T., Mittal, A., Paul, S., Rao, V. J., Chittora, H., Kashyap, D., Palakodeti, D., Kumarasamy Thangaraj, K., et al. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2021-107866 · Cited by 10
Enrichment of titin-truncating variants in exon 327 in dilated cardiomyopathy and its relevance to reduced nonsense-mediated mRNA decay efficiency
Kim, Y., Ha, C., Shin, S., Park, J., Jang, J., & Kim, J. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1087359 · Cited by 9
The potential of myosin and actin in nanobiotechnology
Månsson, A. (2023) · Journal of Cell Science · doi:10.1242/jcs.261025 · Cited by 10
Molecular analysis of dilated and left ventricular noncompaction cardiomyopathies in Egyptian children
Mehaney, D. A., Haghighi, A., Embaby, A. K., Zeyada, R. A., Darwish, R. K., Elfeel, N. S., Abouelhoda, M., El-Saiedi, S. A., Gohar, N. A., & Seliem, Z. S. (2021) · Cardiology in the Young · doi:10.1017/s1047951121002055 · Cited by 9
Microbiota Modulates Cardiac Transcriptional Responses to Intermittent Hypoxia and Hypercapnia
Zhou, D., Xue, J., Miyamoto, Y., Poulsen, O., Eckmann, L., & Haddad, G. G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.680275 · Cited by 9
The role of genetic testing in management and prognosis of individuals with inherited cardiomyopathies
Hespe, S., Gray, B. R., Puranik, R., Peters, S. A., Sweeting, J., & Ingles, J. (2024) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2024.06.002 · Cited by 9
New insights provided by myofibril mechanics in inherited cardiomyopathies.
Lin, Y., Yap, J. J. L., Ramachandra, C. J. A., & Hausenloy, D. J. (2019) · PubMed · Cited by 9
A transcriptional enhancer regulates cardiac maturation
Htet, M., Lei, S., Bajpayi, S., Gangrade, H., Arvanitis, M., Zoitou, A., Murphy, S. A., Chen, E. Z., Koleini, N., Lin, B. L., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00484-2 · Cited by 9
Suspended Tissue Open Microfluidic Patterning (STOMP)
Haack, A. J., Brown, L. G., Goldstein, A. J., Mulimani, P. S., Berthier, J., Viswanathan, A. R., Kopyeva, I., Whitten, J. M., Lin, A., Nguyen, S. H., et al. (2025) · Advanced Science · doi:10.1002/advs.202501148 · Cited by 9
A Family with Myh7 Mutation and Different Forms of Cardiomyopathies
Catrina, B. I., Batâr, F., Bălţat, G., Bitea, I. C., Puia, A., Stoia, O., Fleacă, R. S., & Teodoru, M. (2023) · Biomedicines · doi:10.3390/biomedicines11072065 · Cited by 8
A Splice Variant of the MYH7 Gene Is Causative in a Family with Isolated Left Ventricular Noncompaction Cardiomyopathy
Myasnikov, R. P., Kulikova, O. V., Meshkov, A. N., Bukaeva, A. A., Kiseleva, A. V., Ershova, A. I., Petukhova, A. V., Divashuk, M. G., Zotova, E. D., Сотникова, Е. А., et al. (2022) · Genes · doi:10.3390/genes13101750 · Cited by 8
Impact of regulatory light chain mutation K104E on the ATPase and motor properties of cardiac myosin
Rasicci, D. V., Kirkland, O. O., Moonschi, F. H., Wood, N. B., Szczesna‐Cordary, D., Previs, M. J., Wenk, J. F., Campbell, K. S., & Yengo, C. M. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202012811 · Cited by 8
Variants in MHY7 Gene Cause Arrhythmogenic Cardiomyopathy
Ferradini, V., Parca, L., Martino, A., Lanzillo, C., Silvetti, E., Calò, L., Caselli, S., Novelli, G., Helmer‐Citterich, M., Sangiuolo, F. C., et al. (2021) · Genes · doi:10.3390/genes12060793 · Cited by 8
Genetics of hypertrophic cardiomyopathy: what is the next step?
Kuusisto, J. (2020) · Heart · doi:10.1136/heartjnl-2020-317043 · Cited by 8
Research Gaps in Pediatric Heart Failure: Defining the Gaps and Then Closing Them Over the Next Decade
Amdani, S. M., Auerbach, S. R., Bansal, N., Chen, S., Conway, J. L., Silva, J. P. D., Deshpande, S. R., HOOVER, J., Lin, K. Y., Miyamoto, S. D., et al. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2023.08.026 · Cited by 8
Genetics of Exertional Heat Illness: Revealing New Associations and Expanding Heterogeneity
Sambuughin, N., Mungunsukh, O., Klein, M. G., Ren, M., Bedöcs, P., Kazman, J. B., Cofer, K., Friel, L. P., McNally, B. A., Kwon, K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011269 · Cited by 7
Pathogenic genes and clinical prognosis in hypertrophic cardiomyopathy
Hong, Y., Xi, H.-T., Yang, X.-Y., SU, W. W., & Li, X. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i1.99595 · Cited by 7
Altered coronary artery function, arteriogenesis and endothelial YAP signaling in postnatal hypertrophic cardiomyopathy
Langa, P., Marszalek, R. J., Warren, C. M., Chowdhury, S. A. K., Hałas, M., Batra, A., Rafael-Clyke, K., Bacon, A., Goldspink, P. H., Solaro, R. J., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1136852 · Cited by 7
Biological nanomotors, driving forces of life
Houdusse, A. (2021) · Comptes Rendus Biologies · doi:10.5802/crbiol.45 · Cited by 7

Authors: Yotti, R., Seidman, C. E., & Seidman, J. G.
Affiliations: Instituto de Salud Carlos III (ES)
Brigham and Women's Hospital (US)
Harvard University (US)
ORCID: Yotti, Raquel
Seidman, Christine E.
Seidman, Jonathan G.
Venue: Annual Review of Genomics and Human Genetics
Publisher: Annual Reviews
Published: 2019-08-31
Volume: 20
Issue: 1
Pages: 129-153
ISSN: 1527-8204 (ISSN-L)
1545-293X
DOI: 10.1146/annurev-genom-083118-015306
OpenAlex: W2936587264
Cited by: 168
References: 154
Citations by year: 2026: 10 · 2025: 17 · 2024: 35 · 2023: 27 · 2022: 24 · 2021: 33 · 2020: 18 · 2019: 4
FWCI: 3.57
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Annual Review of Genomics and Human Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
Fondation Leducq
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
National Institutes of Health
Instituto de Salud Carlos III (PI15/02229)
National Heart, Lung, and Blood Institute (R01HL084553)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: hypertrophic cardiomyopathy, dilated cardiomyopathy, pathogenic variants, myocardial relaxation, sarcomerogenesis, cardiac contractility, energy conservation, therapeutic target, cardioprotection
MeSH terms: Myosin Binding Protein C, Benzylamines, Cardiomyopathy, Dilated, Cardiomyopathy, Hypertrophic, Cardiotonic Agents, Carrier Proteins, Humans, Mutation, Myocardial Contraction, Myocardium, Sarcomeres, Uracil, Urea, Gene Expression, RNA-Binding Proteins, Myosin Heavy Chains, Troponin T, Cardiac Myosins, Connectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks